Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab®)

by Diane Seimetz
Published 2011-01-01

From fiction to science: clinical potentials and regulatory considerations of gene editing

by Maria Schacker, Diane Seimetz
Published 2019-10-01

Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape

by Mariya Gromova, Annegret Vaggelas, Gabriele Dallmann, Diane Seimetz
Published 2020-12-01